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with infection. A composite risk score was created using retained factors in stepwise multivariable logistic regression modeling.
RESULTS: A cohort of 74 patients was identified with obstructive urolithiasis evaluated for decompression due to concern for UTI of whom only 37 (50%) had a true UTI. The standard model of serum WBC > 15 or temperature > 38 C had an AUC of only 0.68 to predict true UTI. Conversely, a data-derived 5-point risk score (1-point for each of the following: positive gram stain, >50 WBCs/hpf on urine microscopy, perinephric fat stranding on CT, serum C-reactive protein (CRP) > 21.95, and serum procalcitonin (PCT) > 0.36) had an AUC of 0.92 ( Figure) . The chances of a true UTI increased from 5% to 60% to 93% among patients with risk scores of 0-1, 2, and 3-5, respectively (p<0.001).
CONCLUSIONS: Currently, only 50% of patients with a suspected UTI and an obstructing stone are ultimately found to have a true UTI. A risk score (consisting of gram stain, pyuria, perinephric fat stranding, CRP, and PCT) outperformed standard clinical variables in predicting a true UTI in patients with obstructing urolithiasis. We are currently validating this score to help elucidate which patients with obstruction and clinical suspicion for infection require decompression.
Source of Funding: none

MP71-09
IN VITRO EVALUATION OF NOVEL SURFACE MODIFYING MOLECULES TO PREVENT BACTERIAL ADHESION TO UROLOGICAL DEVICES
Christopher Munday*, London, Canada; Alexandra Piotrowicz, Toronto, Canada; Kyle MacDonald, London, Canada; Antonio Cillero, Jeannette Ho, Toronto, Canada; John Denstedt, Jeremy Burton, London, Canada INTRODUCTION AND OBJECTIVES: Bacterial adhesion and biofilm formation on urological devices such as stents and catheters is an undesirable phenomena that can lead to device-related infection and other co-morbidities. A range of potential technologies utilizing both passive mechanisms and active antimicrobials have been developed to combat this issue, but clinical efficacy remains limited. The objective of this study was to investigate the ability of a novel passive surface modification technology using fluorinated surface modifying molecules (SMMs) to address this clinical need.
METHODS: Polyurethane control and SMM-modified prototypes for testing (rods or catheter tubing) were prepared using standard melt extrusion processes. X-ray photoelectron spectroscopy confirmed the presence of SMMs at device surfaces. Efficacy of devices to resist bacterial adhesion was assessed using both static and flow models. Static experiments consisted of sample incubation in bacterial inoculum followed by sonication to detach adhered bacteria and quantification by plate counts. Flow experiments were conducted using a custom circulating flow system with artificial urine.
RESULTS: SMM-modified prototypes showed up to 2 log lower microbial adhesion compared to unmodified controls after 2h incubation in buffer inoculated with various gram positive, gram negative bacteria or yeast. The anti-adhesive property of SMM prototypes was confirmed in both artificial and human urine with three uropathogens (Escherichia coli, Enterococcus faecalis, Proteus mirabilis), as well as in clinical urine samples from patients with ureteral stents, where SMM-modified samples showed reduced attachment of mixed bacterial populations after 24h of incubation. Experiments under flow demonstrated potential of SMM-modified surfaces to resist adhesion in dynamic environments and for extended time frames, with 5 log lower attachment of E. coli observed on SMM-modified tubing vs controls at both 1 and 3 days post inoculation. Corresponding reductions in biofilm formation were confirmed with crystal violet staining and scanning electron microscopy.
CONCLUSIONS: Modification of urological devices with SMMs may be an effective strategy to reduce bacterial adhesion and biofilm formation. The passive nature of the SMMs is advantageous as it provides a stable surface not subject to depletion or de-activation of the functional entity over time, as may be the case for surfaces modified with eluting or active antimicrobials.
Source of Funding: Mitacs Accelerate Postdoctoral Fellowship
MP71-10 THE DIAGNOSTIC VALUES OF SYMPTOMS FOR ACUTE UNCOMPLICATED CYSTITIS e EVALUATION OF THE PROPOSED UPDATED FDA GUIDELINES
Jakhongir Alidjanov*, Gießen, Germany; Kurt Naber, Straubing, Germany; Adrian Pilatz, Gießen, Germany; Ulugbek Abdufattaev, Tashkent, Uzbekistan; Florian Wagenlehner, Gießen, Germany INTRODUCTION AND OBJECTIVES: Recently, US Food and Drug Administration (FDA) has proposed to use at least two of the four following symptoms for diagnosis of acute uncomplicated cystitis (AC) in women: dysuria, urinary frequency, urinary urgency, and suprapubic pain. We aimed to reevaluate the diagnostic values of symptoms for AC, using the Acute Cystitis Symptom Score (ACSS), having been validated in several languages.
METHODS: The data derived from the ACSS database were analyzed and used for validating the updated FDA guidelines. Different diagnostic values of the signs, symptoms and their severity were assessed. «Model fit» analysis of the linear models and 2x2 contingency tables were used for basic statistical analysis.
RESULTS: Of the 911 respondents from 7 different countries, 872 (median for age ) were selected for the analysis. Respondents were allocated to groups of Patients (n[453) and Controls (n[418) according to the diagnosis of a physician concerning the presence or absence of AC, based on physical and laboratory findings. The accuracy of the diagnosis increased significantly for all symptoms when the severity of a symptom was included in the analysis. Highest diagnostic values were shown by dysuria in the «model fit» and odds ratio analyses, both for the presence and severity of this symptom. Urinary frequency and visible blood in the urine had no significant association with the diagnosis of AC when the analysis was based only on the presence or absence of signs. Inclusion the severity of urinary frequency into the analysis increased the strength of its association with AC up to significant values. The diagnostic values of suprapubic pain and sense of incomplete bladder emptying were about the same and had a significant positive association with AC. The inclusion of the severity into the analysis decreased the association of suprapubic pain with AC to insignificant values.
CONCLUSIONS: The severity of the symptoms rather than their presence itself is essential for an accurate diagnosis of AC. Dysuria has the highest diagnostic value of the typical symptoms. In addition to the four symptoms proposed by the FDA, we propose also to include a sense of incomplete bladder emptying into the list of additional symptoms for the diagnosis of AC. It is, however, necessary to consider the
